Minerva Neurosciences Inc NERV
NASDAQ · United States · Health Technology
$3.29+0.06 (+1.86%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-07 | -0.14 | -0.19 | +27.6% | $0 | — | +4.1%$4.44→$4.62 |
| Q1 2026 | 2026-05-05 | -0.17 | -0.13 | -30.8% | — | — | -1.6%$6.33→$6.23 |
| Q4 2025 | 2026-03-11 | -25.51 | -0.30 | -8,403.3% | — | — | -3.1%$7.94→$7.69 |
| Q3 2025 | 2025-11-05 | -0.36 | -0.35 | -2.9% | — | — | -0.8%$3.67→$3.64 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.